Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Study of EUS-guided Gallbladder Drainage vs Choledochoduodenostomy as First Line in Malignant Distal Obstruction in Palliative Patients (CARPEGIEM Trial): an Open-label, Randomized Controlled Clinical Trial

NCT06375967 is registered in ClinicalTrials.gov with Hospital Universitari de Bellvitge as lead sponsor.

NCT NCT06375967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06375967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Study of EUS-guided Gallbladder Drainage vs Choledochoduodenostomy as First Line in Malignant Distal Obstruction in Palliative Patients (CARPEGIEM Trial): an Open-label, Randomized Controlled Clinical Trial
Lead sponsor
Hospital Universitari de Bellvitge
Phase
Not applicable
Overall status
Suspended
Start date
October 18, 2024
Completion date
October 31, 2027
Enrollment
128 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract neoplasms, malignant biliary obstruction, pancreatic cancer non-resectable